TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) reports that it has ...

Li-FT Power (TSXV: LIFT; US-OTC: LIFFF) reported on Tuesday one of its strongest assays yet of 1.34% lithium oxide (Li 2 O) ...

Labcorp's nAbCyte Assay has been approved by the FDA as a companion diagnostic for Pfizer's gene therapy in treating ...

April 30, 2024) - EV Minerals Corporation (CSE: EVM) (FSE: RLC) (the "Company" or "EVM") is pleased to report initial assay ...

Alpha Exploration Ltd. (TSXV: ALEX) ("Alpha" or the "Company") announces final results from the first phase of its 2024 ...

DeepUll showcased its UllCore platform and UllCore BSI Test, a one-hour multiplex PCR assay targeting 95 percent of ...

Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This ...

Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its ...

Labcorp (LH) announced the FDA has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a companion diagnostic to determine patient ...

(RTTNews) - ANGLE plc (AGL.L, ANPCY) said that it has reached an agreement with AstraZeneca PLC, to develop and validate a methodology leveraging ANGLE's existing DNA damage response or "DDR" assay ...

Our TNM Drill Down features highlights of the top gold assays from the April 19-26 period, with holes ranked by gold grade x ...

Only platform that meets all regulatory requirements to establish CHO genetic stability with a single test ...